Brief: Fusen Pharmaceutical Sees Profit Attributable RMB10 Million To RMB25 Million For Six Months
10/08/2023 14:44
Aug 10 (Reuters) - Fusen Pharmaceutical Co Ltd
1652.HK :
* FUSEN PHARMACEUTICAL CO LTD SEES PROFIT ATTRIBUTABLE
RMB10
MILLION TO RMB25 MILLION FOR SIX MONTHS
* FUSEN PHARMACEUTICAL CO LTD SEES INCREASE IN REVENUE FOR
SIX
MONTHS BY NOT LESS THAN 90%
Further company coverage: 1652.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusen Pharmaceutical
See all newsBrief: Fusen Pharmaceutical Logs HY Loss Attributable RMB13.6 Million
Brief: Fusen Pharmaceutical Says Doxazosin Mesylate Extended-Release Tablets Approved For Marketing In China
Brief: Fusen Pharmaceutical Says Peramivir Injection First Neuraminidase Inhibitor Approved In China For Intravenous Influenza Treatment
Brief: Fusen Pharmaceutical Says Investors To Contribute RMB300 Mln For 34% Stake Subscription Of Henan Fusen Pharmaceutical
Brief: Fusen Pharmaceutical Says Piracetam Injection Approved For Marketing By NMPA